220 related articles for article (PubMed ID: 15785372)
1. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
[TBL] [Abstract][Full Text] [Related]
2. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
3. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
4. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood.
Schröder C; Pfeiffer S; Wu G; Zorn GL; Ding L; Allen C; Harrison RA; White DJ; Azimzadeh AM; Pierson RN
J Heart Lung Transplant; 2003 Dec; 22(12):1365-75. PubMed ID: 14672751
[TBL] [Abstract][Full Text] [Related]
5. Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
Lam TT; Hausen B; Boeke-Purkis K; Paniagua R; Lau M; Hook L; Berry G; Higgins J; Duthaler RO; Katopodis AG; Robbins R; Reitz B; Borie D; Schuurman HJ; Morris RE
Xenotransplantation; 2004 Nov; 11(6):517-24. PubMed ID: 15479461
[TBL] [Abstract][Full Text] [Related]
6. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement.
Pierson RN; Kasper-Konig W; Tew DN; Young VK; Dunning JJ; Horsley J; Carey NR; Wallwork J; White DJ
Transplantation; 1997 Feb; 63(4):594-603. PubMed ID: 9047157
[TBL] [Abstract][Full Text] [Related]
7. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
[TBL] [Abstract][Full Text] [Related]
8. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
9. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion.
Macchiarini P; Oriol R; Azimzadeh A; de Montpreville V; Rieben R; Bovin N; Mazmanian M; Dartevelle P
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):831-43. PubMed ID: 9806390
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a pig-to-goat orthotopic lung xenotransplantation model to study beyond hyperacute rejection.
Macchiarini P; Oriol R; Azimzadeh A; de Montpreville V; Wolf P; Dartevelle P
J Thorac Cardiovasc Surg; 1999 Nov; 118(5):805-14. PubMed ID: 10534685
[TBL] [Abstract][Full Text] [Related]
11. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
[TBL] [Abstract][Full Text] [Related]
12. Absence of Gal epitope prolongs survival of swine lungs in an ex vivo model of hyperacute rejection.
Nguyen BN; Azimzadeh AM; Schroeder C; Buddensick T; Zhang T; Laaris A; Cochrane M; Schuurman HJ; Sachs DH; Allan JS; Pierson RN
Xenotransplantation; 2011; 18(2):94-107. PubMed ID: 21496117
[TBL] [Abstract][Full Text] [Related]
13. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood.
Pierson RN; Pino-Chavez G; Young VK; Kaspar-Konig W; White DJ; Wallwork J
J Heart Lung Transplant; 1997 Feb; 16(2):231-9. PubMed ID: 9059935
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of cardiac xenograft survival by depletion of complement.
Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
[TBL] [Abstract][Full Text] [Related]
15. Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates.
Verbakel CA; de Bruin RW; Bonthuis F; Jonker M; Dekker S; Marquet RL; IJzermans JN
Xenotransplantation; 2001 Nov; 8(4):284-91. PubMed ID: 11737854
[TBL] [Abstract][Full Text] [Related]
16. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model.
Blum MG; Collins BJ; Chang AC; Zhang JP; Knaus SA; Pierson RN
Xenotransplantation; 1998 Feb; 5(1):35-43. PubMed ID: 9507731
[TBL] [Abstract][Full Text] [Related]
17. Hyperacute rejection of mouse lung by human blood: characterization of the model and the role of complement.
Schröder C; Wu GS; Price E; Johnson JE; Pierson RN; Azimzadeh AM
Transplantation; 2003 Sep; 76(5):755-60. PubMed ID: 14501848
[TBL] [Abstract][Full Text] [Related]
18. Improved suppression of circulating complement does not block acute vascular rejection of pig-to-rhesus monkey cardiac transplants.
Chen G; Sun QY; Wang XM; Shen SQ; Guo H; Wang H; Wu Y; Wang WY; Xiong YL; Chen S
Xenotransplantation; 2004 Mar; 11(2):123-32. PubMed ID: 14962274
[TBL] [Abstract][Full Text] [Related]
19. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
[TBL] [Abstract][Full Text] [Related]
20. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
